vs
Amarin Corp plc（AMRN）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是REDWOOD TRUST INC的1.7倍（$45.1M vs $25.9M），REDWOOD TRUST INC净利率更高（77.2% vs -23.3%，领先100.5%），Amarin Corp plc同比增速更快（7.0% vs -6.1%），过去两年Amarin Corp plc的营收复合增速更高（-18.3% vs -41.0%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
AMRN vs RWT — 直观对比
营收规模更大
AMRN
是对方的1.7倍
$25.9M
营收增速更快
AMRN
高出13.1%
-6.1%
净利率更高
RWT
高出100.5%
-23.3%
两年增速更快
AMRN
近两年复合增速
-41.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $25.9M |
| 净利润 | $-10.5M | $20.0M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | — |
| 净利率 | -23.3% | 77.2% |
| 营收同比 | 7.0% | -6.1% |
| 净利润同比 | 33.0% | 402.6% |
| 每股收益（稀释后） | — | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNRWT
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $25.9M | ||
| Q3 25 | $49.7M | $15.0M | ||
| Q2 25 | $72.7M | $13.8M | ||
| Q1 25 | $42.0M | $27.9M | ||
| Q4 24 | $62.3M | $27.6M | ||
| Q3 24 | $42.3M | $25.5M | ||
| Q2 24 | $67.5M | $67.4M |
净利润AMRNRWT
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $20.0M | ||
| Q3 25 | $-7.7M | $-7.7M | ||
| Q2 25 | $-14.1M | $-98.5M | ||
| Q1 25 | $-15.7M | $16.1M | ||
| Q4 24 | $-48.6M | $-6.6M | ||
| Q3 24 | $-25.1M | $14.8M | ||
| Q2 24 | $1.5M | $15.5M |
毛利率AMRNRWT
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNRWT
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | — | ||
| Q3 25 | -22.4% | -9.0% | ||
| Q2 25 | -22.0% | -679.0% | ||
| Q1 25 | -39.9% | 80.2% | ||
| Q4 24 | -84.3% | -1.3% | ||
| Q3 24 | -59.5% | 86.1% | ||
| Q2 24 | -0.8% | 30.3% |
净利率AMRNRWT
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 77.2% | ||
| Q3 25 | -15.6% | -51.4% | ||
| Q2 25 | -19.4% | -712.0% | ||
| Q1 25 | -37.4% | 57.8% | ||
| Q4 24 | -78.0% | -24.0% | ||
| Q3 24 | -59.4% | 58.1% | ||
| Q2 24 | 2.3% | 23.0% |
每股收益（稀释后）AMRNRWT
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.11 | ||
| Q3 25 | $-0.02 | $-0.08 | ||
| Q2 25 | $-0.03 | $-0.76 | ||
| Q1 25 | $-0.04 | $0.10 | ||
| Q4 24 | $-0.12 | $-0.08 | ||
| Q3 24 | $-0.06 | $0.09 | ||
| Q2 24 | $0.00 | $0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $982.6M |
| 总资产 | $645.8M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNRWT
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $255.7M | ||
| Q3 25 | $286.6M | $226.3M | ||
| Q2 25 | $298.7M | $302.0M | ||
| Q1 25 | $281.8M | $259.9M | ||
| Q4 24 | $294.2M | $245.2M | ||
| Q3 24 | $305.7M | $253.7M | ||
| Q2 24 | $306.7M | $275.6M |
股东权益AMRNRWT
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $982.6M | ||
| Q3 25 | $458.9M | $999.0M | ||
| Q2 25 | $464.9M | $1.1B | ||
| Q1 25 | $473.7M | $1.2B | ||
| Q4 24 | $486.2M | $1.2B | ||
| Q3 24 | $531.4M | $1.2B | ||
| Q2 24 | $551.9M | $1.2B |
总资产AMRNRWT
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $23.7B | ||
| Q3 25 | $659.8M | $22.6B | ||
| Q2 25 | $670.1M | $21.3B | ||
| Q1 25 | $655.7M | $19.9B | ||
| Q4 24 | $685.3M | $18.3B | ||
| Q3 24 | $750.6M | $18.4B | ||
| Q2 24 | $799.9M | $16.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRNRWT
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $-10.1B | ||
| Q3 25 | $-12.7M | $-2.7B | ||
| Q2 25 | $16.6M | $-2.1B | ||
| Q1 25 | $-12.5M | $-2.0B | ||
| Q4 24 | $-13.3M | $-5.9B | ||
| Q3 24 | $-2.4M | $-2.1B | ||
| Q2 24 | $-2.7M | $-2.0B |
现金转化率AMRNRWT
| Q1 26 | — | — | ||
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | -1.81× | -126.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
RWT
暂无分部数据
